NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

FDA RTOR combined with Project Orbis would be the best, most efficient & expedient path forward for DCVax-L approval in the US, UK, Canada & Germany.

I believe & hope that this is the pathway that NWBio has chosen.

ATLnsider,

I agree.

From the same presentation:

RTOR

Selection Criteria:

-applications likely to demonstrate improvements over available therapy.
-includes breakthrough therapy and priority review designations.